• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Abiraterone--what is wrong with the adrenal glands?

作者信息

Schmid Sabine, Fornaro Jürgen, Rothermundt Christian, Omlin Aurelius, Brändle Michael, Rupp Niels J, Gillessen Silke

机构信息

Department of Medical Oncology, Kantonsspital St Gallen, St Gallen, Switzerland.

Department of Radiology, Kantonsspital St Gallen, St Gallen, Switzerland.

出版信息

Clin Genitourin Cancer. 2014 Aug;12(4):e133-7. doi: 10.1016/j.clgc.2014.01.008. Epub 2014 Feb 4.

DOI:10.1016/j.clgc.2014.01.008
PMID:24583161
Abstract
摘要

相似文献

1
Abiraterone--what is wrong with the adrenal glands?阿比特龙——肾上腺怎么了？
Clin Genitourin Cancer. 2014 Aug;12(4):e133-7. doi: 10.1016/j.clgc.2014.01.008. Epub 2014 Feb 4.
2
Abiraterone in heavily pretreated patients with metastatic castrate-resistant prostate cancer: final analysis of overall survival.阿比特龙用于多线治疗后的转移性去势抵抗性前列腺癌患者：总生存的最终分析
Anticancer Drugs. 2015 Sep;26(8):910-1. doi: 10.1097/CAD.0000000000000258.
3
[Study on the therapy of castration-resistant prostate cancer: randomized phase II study of abiraterone acetate plus LHRH therapy vs. abiraterone acetate without LHRH therapy in patients with progressive chemotherapy-naïve castration-resistant prostate cancer [SPARE - AP 67/11 of the Association of Urogenital Oncology (AUO)]].
Urologe A. 2014 Nov;53(11):1665-7. doi: 10.1007/s00120-014-3643-9.
4
[Concomitant use of abiraterone acetate and triptorelin in patients with castration-resistant prostate cancer].醋酸阿比特龙与曲普瑞林联合用于去势抵抗性前列腺癌患者
Urologiia. 2016 Feb(1):58-61.
5
[ASC-J9 for castration-resistant prostate cancer].[用于去势抵抗性前列腺癌的ASC-J9]
Nihon Rinsho. 2014 Dec;72(12):2126-9.
6
Abiraterone-induced rhabdomyolysis: A case report.阿比特龙诱发的横纹肌溶解症：一例报告。
J Oncol Pharm Pract. 2017 Mar;23(2):148-151. doi: 10.1177/1078155215620921. Epub 2016 Jul 9.
7
Paraneoplastic Syndrome Secondary to Treatment Emergent Neuroendocrine Tumor in Metastatic Castration-resistant Prostate Cancer: A Unique Case.转移性去势抵抗性前列腺癌中治疗突发神经内分泌肿瘤继发的副肿瘤综合征：一例独特病例
Clin Genitourin Cancer. 2019 Feb;17(1):e56-e60. doi: 10.1016/j.clgc.2018.09.002. Epub 2018 Sep 7.
8
Abiraterone-induced rhabdomyolysis resulting in acute kidney injury: A case report and review of the literature.阿比特龙诱发横纹肌溶解症导致急性肾损伤：一例病例报告及文献综述。
J Oncol Pharm Pract. 2018 Jun;24(4):314-318. doi: 10.1177/1078155217701294. Epub 2017 Mar 29.
9
Abiraterone acetate plus prednisone versus prednisone alone in chemotherapy-naive men with metastatic castration-resistant prostate cancer: patient-reported outcome results of a randomised phase 3 trial.醋酸阿比特龙联合泼尼松对比单独泼尼松用于化疗初治转移性去势抵抗性前列腺癌男性患者：一项随机 3 期临床试验的患者报告结局结果。
Lancet Oncol. 2013 Nov;14(12):1193-9. doi: 10.1016/S1470-2045(13)70424-8. Epub 2013 Sep 25.
10
Treating metastatic prostate cancer now and in the future.现在及未来对转移性前列腺癌的治疗。
Bull Am Coll Surg. 2014 Sep;99(9):55-7.

引用本文的文献

1
PSA response following the 'steroid switch' in patients with castration-resistant prostate cancer treated with abiraterone: A case report.阿比特龙治疗的去势抵抗性前列腺癌患者“类固醇转换”后的前列腺特异性抗原反应：一例报告
Oncol Lett. 2018 Oct;16(4):5383-5388. doi: 10.3892/ol.2018.9321. Epub 2018 Aug 17.
2
Switching and withdrawing hormonal agents for castration-resistant prostate cancer.去势抵抗性前列腺癌的激素药物转换和停药。
Nat Rev Urol. 2015 Jan;12(1):37-47. doi: 10.1038/nrurol.2014.345.